Viewing Study NCT02144194


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-01-05 @ 8:55 PM
Study NCT ID: NCT02144194
Status: UNKNOWN
Last Update Posted: 2017-02-09
First Post: 2014-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca
Sponsor: Cancer Research Group - Collaborative Group, Beirut, Lebanon.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module